Facile green synthesis of Ag-Cu decorated ZnO nanocomposite for effective removal of toxic organic compounds and an efficient detection of nitrite ions.

A facile and eco-friendly green synthesis of silver-copper@zinc oxide (Ag-Cu@ZnO) nanocomposite using Acacia caesia flower extract and their application on catalytic reduction of toxic compounds and electrochemical sensing of nitrite ions are reported. The phytochemicals present in the extract were utilized for the Ag-Cu metal nanoparticles synthesis and also enhanced the binding capability between ZnO and Ag-Cu NPs. The synthesized nanocomposites were characterized by XRD, UV-Vis spectroscopy, Raman spectra, FTIR, SEM, TEM, EDX, XPS and ICP-AES for the formation of Ag-Cu NPs on ZnO. The Ag-Cu@ZnO nanocomposite showed better catalytic efficiency as compared to monometallic nanoparticles for 4-nitrophenol to 4-aminophenol conversion and Rhodamine B and Congo red dye degradation with 99% efficiency up to four cycles. The Ag-Cu@ZnO modified GC electrode showed enhanced catalytic activity towards nitrite oxidation, and it exhibited better performance compared to the other nanocomposites. An appreciable detection limit (17 µM) was achieved with excellent sensitivity for nitrite detection. The sensor was highly selective even in a many-fold higher concentration of co-existing interfering compounds. The good catalytic and electrochemical sensing is mainly ascribed due to the synergistic effect of Ag-Cu on the ZnO in the Ag-Cu@ZnO nanocomposite materials.

Significant intraoperative right ventricular outflow gradients after repair for tetralogy of Fallot: to revise or not to revise?

BACKGROUND: This study was performed to define alternative parameters for the management of intraoperative residual right ventricular outflow obstruction (RVOTO) after transatrial repair of tetralogy of Fallot (ToF) in order to differentiate those requiring immediate revision from those who do not. METHODS: Since October 1995, 166 patients of ToF underwent transatrial repair. Postbypass residual RVOTO was assessed by surgeon's subjective impression, direct intracardiac pressure measurements, and intraoperative echocardiography (IOE). RVOTO was labeled "significant" whenever it exceeded a gradient of 40 mm Hg on IOE or right ventricular to left ventricular pressure ratio (pRV/LV) exceeded 0.85. Further, on IOE, significant RVOTO was defined "fixed", if there was no change in RVOT dimensions during the cardiac cycle, along with the presence of anatomic substrate for obstruction, and "dynamic" if RVOT dimensions increased appreciably in diastole. Postoperative course and follow-up echocardiograms of all patients were analyzed. RESULTS: Significant RVOTO was detected in 58 (35%) patients (mean gradient 54 mm Hg). Seven (12%) of them with fixed obstruction (mean 46 mm Hg) underwent immediate surgical revision, while the remaining 51 patients with mean gradient of 78 mm Hg (including 10 patients with pRV/LV ratio of > or = 1.0) with dynamic obstruction did not undergo revision. There were six (3.6%) early deaths. Operative mortality and postoperative morbidity were not related to higher residual gradients, although the first 15 such patients had longer intensive care stay and inotropic support, in which this was done electively. On follow-up (mean 18.5 months), outflow gradients declined sharply (mean 16 mm Hg) irrespective of the severity of intraoperative gradients (p < 0.001). There were no reoperations or late deaths. CONCLUSIONS: This study shows that: 1) existing parameters for immediate revision of residual RVOTO possibly need to be reviewed; 2) intraoperative echocardiography helps in differentiating "fixed" from "dynamic" obstruction and helps obviate needless revisions; and 3) dynamic RVOT gradients decline significantly irrespective of their severity after transatrial repair of ToF.